Fusion event
HBV-CCDC58P2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CTCTTTACGCGGACTCCCCGTCTGTGCCTTCTCATCTGCCGGACCGTGTGCACTTCGCTTCACCTCTGCACGTCGCATGGAGACCACCGTGAACGCCCAC| |CAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACT
End
52722861/50963101 (Hg38)
Nearest miRNA
hsa-mir-1265/Upstream/1977514; hsa-mir-107/Downstream/336472;
Upstream sequence
GGAGGCTTGAAGTGAATTTGGCAGTATTCGTTAAACACCTTCCAGCTCCTTTCATTTACCACTCTTCAACATTCAGTTCTGACTGCATCCATTTCAACTT
Downstream sequence
TTTCTGCTCTTTTCTAAGTTGCTTTAATAATGTTAAATCATCCAAATTTTTATCTTTCTCTTCTTGGAAGTTTTTTACTACTGCTGTGGTCTGGACTATA
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.